Related articles

In the journey of cancer recovery, many patients and their families genuinely want to “do something” to help the body. However, not everything that seems healthy is actually suitable during cancer care.
Without proper medical supervision or data-driven personalization, well-intentioned habits can sometimes slow recovery, disrupt treatment, or even cause harm.

Because doing more doesn’t always mean doing what’s right
Cancer care is a deeply personal journey, yet many people walk this path relying only on standardized treatments or generic advice.
They take every supplement, follow every instruction, and still feel fatigued, emotionally drained, or slow to recover.
Why? Because effective cancer care is not about doing everything, but about doing the right things for your body—at the right time.

During periods of intense physical stress or ongoing medical care, many individuals experience persistent fatigue, reduced immunity, and a general sense of being unwell.
These symptoms are often linked to increased oxidative stress, immune system demands, and cellular repair needs.
One clinically supported supportive option that has gained increasing attention is High-Dose Intravenous Vitamin C (IVC) Therapy.

When we talk about cancer care, the focus often centers on active treatments like surgery, chemotherapy, or targeted therapies. However, supportive care strategies also play a critical role in helping the body recover, maintain stability, and rebuild its strength. Among these strategies, intravenous nutritional immunoglobulin therapy (IVIG) is emerging as a promising and gentle option for additional support.

In cancer care, most of the focus is placed on tumor markers, imaging results, or responses to treatment. Yet one often-overlooked blood marker—albumin—can quietly reflect a patient’s overall condition, prognosis, and even survival.
Though seemingly simple, this protein tells a deeper story about the body’s nutritional status, inflammation levels, and recovery capacity.